Innovation in Medical Evidence Development and Surveillance (IMEDS)
A public-private collaboration for evidence generation
Introducing an Expanded Access Navigator to help patients and physicians better understand how to access investigational drugs outside of clinical trials.
On November 19, 2018, the Reagan-Udall Foundation for the FDA will convene an all-day public meeting to discuss protocol-based Expanded Access Programs, and to identify the challenges and opportunities in utilizing real-world evidence from these programs for regulatory decisions. Click for more information.